跳至主要内容
临床试验/JPRN-UMIN000031302
JPRN-UMIN000031302已完成未知

Metachronous gastric cancer prevention with aspirin:A multi-center randomized trial - MEGA trial

MEGA trial Group0 个研究点目标入组 50 人开始时间: 2018年2月14日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Allergy to aspirin treatment 2) Other gastric neoplasm including low grade adenoma remain 3) A history of H. pylori eradication therapy received more than 5 years ago 4) Lesions of Siewert Type II (<2 cm from the OGJ at the epicenter) 5) A history of gastric surgery 6) Severe co-morbidities and estimated life expectancy less than 3 years 7) Already on aspirin or other antithrombotic drugs prior to randomization 8) Using NSAIDs 9) Using Metformin 10) A history of peptic ulcers 11) A history of stroke 12) Receiving chemotherapy 13) Disorder of blood coagulation or platelet < 100,000/microliter 14) Pregnancy 15) Breast-feeding 16) Lack of informed consent

研究者

发起方
MEGA trial Group

相似试验